High impact

Uncovering repurposed medicines to fight liver fibrosis

What happened

Google DeepMind researchers have used AI to identify existing, FDA-approved drugs that could be repurposed to treat liver fibrosis, a serious condition involving scar tissue buildup in the liver. By analyzing biological data and predicting drug interactions, the AI successfully flagged potential treatments much faster than traditional methods. This breakthrough could drastically accelerate the discovery of viable therapies for hard-to-treat diseases using medicines we already have.

Why it matters

This milestone highlights the growing practical value of AI in biotechnology, moving predictive models from theoretical biology to tangible medical breakthroughs. It signals a major shift where pharmaceutical discovery relies increasingly on computational screening, opening new commercial avenues for AI-driven drug repositioning.

More from Google

Google Search gets a major upgrade with Gemini 4 HydrogenGoogle · 12 Nov 2026Introducing Gemini 4 HydrogenGoogle · 12 Nov 2026Gemini 4 HydrogenGoogle · 12 Nov 2026Gemini Decisions API: Fast, calibrated multimodal decisionsGoogle · 11 Nov 2026Try Tabletop: Customizable, collaborative spaces for groups to plan, play and do more together.Google · 11 Nov 2026

This page was collected from deepmind.google and summarised automatically by AIPulsee's pipeline. See how it runs.